Contegra (R) pulmonary valved conduit for the correction or reconstruction of the outflow tract of the right ventricle in congenital heart malformations in patients aged under 18
Parrella, A, Merlin, T
Record ID 32006000600
English
Authors' results and conclusions:
The available level III-2 evidence indicates this technology is potentially safe and effective in the short term, although there is uncertainty regarding its safety and effectiveness in the long-term. The target group for this technology in Australia is small.
Authors' recommendations:
HealthPACT recommends that this technology be monitored.
Details
Project Status:
Completed
Year Published:
2004
URL for published report:
Not Available
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Australia
MeSH Terms
- Adolescent
- Bioprosthesis
- Child
- Heart Valve Prosthesis
- Heart Defects, Congenital
- Ventricular Outflow Obstruction
Contact
Organisation Name:
Adelaide Health Technology Assessment
Contact Address:
School of Public Health, Mail Drop 545, University of Adelaide, Adelaide SA 5005, AUSTRALIA, Tel: +61 8 8313 4617
Contact Name:
ahta@adelaide.edu.au
Contact Email:
ahta@adelaide.edu.au
Copyright:
Adelaide Health Technology Assessment (AHTA)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.